Source Natural Foods and Herbal Supplements Limited (BOM:531398)
India · Delayed Price · Currency is INR 107.00
-0.60 (-0.56%)
At close: Jul 28, 2026
BOM:531398 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 689 | 698 | 1,340 | 567 | 572 | 612 | |
Market Cap Growth | -21.53% | -47.87% | 136.11% | -0.83% | -6.42% | -35.81% |
Enterprise Value | 745 | 679 | 1,328 | 538 | 581 | 590 |
Last Close Price | 107.00 | 108.50 | 208.15 | 88.16 | 88.90 | 95.00 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 20.27 | 20.55 | 46.14 | 32.68 | 26.98 | 25.14 |
PS Ratio | 0.98 | 0.99 | 2.98 | 2.08 | 2.89 | 2.84 |
PB Ratio | 2.67 | 2.71 | 5.99 | 2.92 | 3.23 | 3.92 |
P/TBV Ratio | 2.67 | 2.71 | 5.99 | 2.92 | 3.23 | 3.92 |
P/FCF Ratio | - | - | - | 21.06 | 22.78 | - |
P/OCF Ratio | - | - | 2045.57 | 21.06 | 22.78 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.06 | 0.97 | 2.96 | 1.97 | 2.94 | 2.74 |
EV/EBITDA Ratio | 12.64 | 11.54 | 29.61 | 14.11 | 18.57 | 15.43 |
EV/EBIT Ratio | 13.50 | 12.32 | 32.16 | 15.69 | 19.64 | 17.32 |
EV/FCF Ratio | - | - | - | 19.97 | 23.11 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.30 | 0.30 | 0.33 | 0.06 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 1.32 | 1.32 | 1.65 | 0.32 | 0.01 | 0.01 |
Debt / FCF Ratio | - | - | - | 0.46 | 0.01 | - |
Net Debt / Equity Ratio | 0.22 | 0.22 | 0.01 | -0.30 | -0.16 | -0.05 |
Net Debt / EBITDA Ratio | 0.95 | 0.95 | 0.04 | -1.54 | -0.92 | -0.22 |
Net Debt / FCF Ratio | -1.80 | -1.80 | -7.69 | -2.17 | -1.15 | 0.37 |
Asset Turnover | 1.83 | 1.83 | 1.48 | 1.18 | 0.97 | 1.18 |
Inventory Turnover | 7.60 | 7.60 | 6.47 | 4.16 | 3.04 | 4.26 |
Quick Ratio | 1.38 | 1.38 | 1.51 | 3.01 | 3.02 | 2.68 |
Current Ratio | 2.18 | 2.18 | 2.03 | 3.97 | 4.33 | 4.27 |
Return on Equity (ROE) | 14.13% | 14.13% | 13.89% | 9.34% | 12.73% | 16.92% |
Return on Assets (ROA) | 8.98% | 8.98% | 8.50% | 9.25% | 9.06% | 11.66% |
Return on Invested Capital (ROIC) | 14.34% | 14.13% | 18.52% | 13.18% | 15.49% | 17.22% |
Return on Capital Employed (ROCE) | 20.90% | 20.90% | 18.00% | 17.10% | 16.40% | 21.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.94% | 4.87% | 2.17% | 3.06% | 3.71% | 3.98% |
FCF Yield | -4.49% | -4.43% | -0.02% | 4.75% | 4.39% | -3.67% |
Buyback Yield / Dilution | 0.01% | 0.01% | -0.12% | -0.06% | 0.12% | 0.06% |
Total Shareholder Return | 0.01% | 0.01% | -0.12% | -0.06% | 0.12% | 0.06% |